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Abstract 
Objective To present an objective method to evaluate gait improvements after a 
tap test in idiopathic normal pressure hydrocephalus (INPH). 
Design Retrospective analysis of gait data. 
Setting Public tertiary care center, day hospital. The gait analysis was performed 
before and 2 to 4 hours after the tap test. 
Participants Participants included patients with INPH (n=60) and age- and sex-
matched controls (n=50; used to obtain reference intervals). From an initial referred 
sample of 79 patients (N=79), we excluded those unable to walk without walking aids 
(n=9) and those with incomplete (pre-/posttap test) gait data (n=10). Thirteen out of 
60 patients were shunted and then reappraised after 6 months. 
Interventions Not applicable. 
Main Outcome Measures Mahalanobis distance from controls, before and after the 
tap test. Eleven gait parameters were combined in a single quantitative score. 
Walking velocity was also evaluated because it is frequently used in tap test 
assessment. 
Results Patients were classified into 2 groups: tap test responders (n=22, 9 of them 
were shunted) and not suitable for shunt (n=38, 4 of them were shunted). In the tap 
test responders group, 9 out of 9 patients improved after shunt. In the not suitable for 
shunt group, 3 out of 4 patients did not improve. Gait velocity increased after the tap 
test in 53% of responders and in 37% of patients not suitable for shunt. 
Conclusions The new method is applicable to clinical practice and allows for 
selecting tap test responders in an objective way, quantifying the improvements. Our 
results suggest that gait velocity alone is not sufficient to reliably assess tap test 
effects. 
 
Keywords Hydrocephalus, normal pressure; Multivariate analysis; Rehabilitation; 
Spinal puncture; Ventriculoperitoneal shunt 
List of abbreviations CSF, cerebrospinal fluid; INPH, idiopathic normal pressure 
hydrocephalus; ROM, range of motion; TT, tap test 
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Normal pressure hydrocephalus is a neurologic condition characterized by an 
enlargement of the ventricles and by a clinical picture named the Hakim triad (gait 
impairment, mental deterioration, urinary incontinence).1, 2, 3, 4, 5, 6, 7, 8 and 9 
The symptoms of the disease can be improved by shunting of cerebrospinal fluid 
(CSF). Shunt surgery is routinely applied to selected patients after careful clinical 
assessment of the potential risks and benefits.10 
The diagnosis relies on convergence of clinical history, physical examination, and 
brain imaging showing a ventricular enlargement.2, 4 and 8 Despite the classic clinical 
picture, the daily diagnosis of the disease is complicated because of the variability in 
its clinical presentation and course. In fact, other frequent conditions of older adults 
(eg, cerebrovascular disease, neurodegenerative disorders, spinal stenosis, primary 
urological disorders) may present similarly to idiopathic normal pressure 
hydrocephalus (INPH).4 Supplemental prognostic tests (eg, intracranial pressure 
monitoring, external lumbar drainage test, measurement of CSF outflow resistance, 
CSF tap test [TT]) have been used in clinical practice to attain a higher specificity and 
sensitivity for diagnosis of INPH and to achieve a reliable prediction of a positive shunt 
response.11 and 12 
Although the CSF tap is regarded as less sensitive than the external lumbar test,8 it 
is largely used because it is considered easy, safe, and inexpensive and is not a time-
consuming test. A positive response of gait disturbances to a 40 to 50 mL TT is 
generally considered to have a high degree of certainty for a favorable response to 
shunt placement. The guidelines of the Japan Neurosurgical Society6 and European 
INPH Multicentre Study Group5, 10 and 12 point out the positive predictive value of 
the TT (73%–100%). Nevertheless, they suggest that a negative result of the CSF TT 
should not exclude patients from surgery because of the test's low sensitivity. In spite 
of the widespread use of the TT to determine shunt responsiveness, instrumented gait 
analysis is very seldom used as an outcome measure.13, 14, 15 and 16 
Patients with INPH frequently show a reduced gait velocity and a diminished and 
highly variable step length. Specific features of their gait disturbance are a broad-
based gait pattern with outward rotated feet and a diminished height of the steps.15 
They also show an augmented duration of the period of double support (ie, 
percentage of the gait cycle in which both feet are in contact with the ground).16 This 
feature is often referred to as magnetic gait to highlight the patient's difficulty in 
raising the foot from the floor during limb advancement. 
Gait improvement after the TT is often evaluated by clinicians in a subjective way 
or by performing simple walks (eg, 10-m walk test).17, 18, 19, 20 and 21 Performing 
the 10-m walk test is the equivalent of measuring the patient's gait velocity. 
Instrumented gait analysis may be an important tool to objectively assess gait 
changes after the TT, therefore helping clinical decision in shunt candidate 
selection.16 Recent advances in gait analysis highlight the importance of evaluating 
uninterrupted walking trials lasting 2 to 3 minutes.22, 23, 24, 25 and 26 This allows 
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for a reliable evaluation of gait parameters because 50 to 150 gait cycles are collected 
and analyzed for each patient. 
The aim of this work is to present an objective method for selecting TT responders, 
based on gait parameters automatically extracted from an instrumented walk. 
 
Methods 
Participants 
Seventy-nine consecutive patients diagnosed with clinical suspected INPH were 
referred to our gait analysis laboratory from the neurosurgery or neurology units, 
between 2011 and 2014, to evaluate gait improvements after a TT. The patients 
generally showed a short-stepped magnetic gait, cognitive disturbances, and in many 
cases, urinary incontinence. All patients were submitted to neuropsychological 
evaluation and brain magnetic resonance imaging. Patients reached our unit early in 
the morning and were assessed a first time by instrumented gait analysis. Then they 
underwent a spinal CSF tap of 30 to 50 mL in the neurosurgery unit. From 2 to 4 
hours after the TT, patients' gait was assessed a second time with the same 
procedure. 
We studied retrospectively our gait analysis database. Patients were excluded from 
the study when they were unable to walk without walking aids (n=9), when they did 
not complete the entire protocol (9 participants missed the post-TT evaluation), or 
when data were corrupted (n=1). Sixty patients (44 men, 16 women; mean age, 
73±8y) were considered for the analysis. Thirteen of these 60 patients underwent 
shunt surgery. All except one were assessed a third time by gait analysis, 6 months 
after surgery. The remaining subject could not perform the gait test because he was 
not able to walk any more. 
The selection of patients to be shunted was based on a clinical report summarizing 
the more relevant gait changes observed after the TT. The report included the 
subjective impressions of the team on movement fluency during gait. It also included 
perceived sensations of patients (or their relatives): they were interviewed by phone 
about gait, memory, and continence within the 24 hours after the TT. 
A control group of 50 volunteers (30 men, 20 women) of similar age (mean age, 
71±12y) was recruited from the local community to obtain reference intervals, in 
normative health conditions, for the studied gait parameters. Controls were clinically 
assessed prior to the gait analysis test to exclude the presence of orthopedic or 
neurologic disorders that could affect their gait. They performed the instrumented gait 
test only once. 
The research reported in this article was undertaken in compliance with the ethical 
principles of the Declaration of Helsinki. 
 
Experimental setup 
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The instrumented test was performed by an easy-to-use, inexpensive, and reliable 
multichannel recording systema used in clinical gait analysis.22, 23, 24, 25 and 26 
Three footswitches were fixed under the heel and the first and fifth metatarsal heads 
of each foot sole (fig 1A), and a knee goniometer was attached to the lateral side of 
each leg (fig 1B). Subjects were instructed to walk barefoot at a self-selected speed. 
They walked back and forth over a 9-m pathway for 2.5 minutes (fig 1C). The system 
recorded, for each lower limb, the foot-floor contact signal and knee flexion-extension 
angle (in the sagittal plane). The sampling frequency was 2kHz. The foot-floor contact 
signal was debounced and converted to a 4-level signal by the system software, 
coding the gait phases of heel contact, flat-foot contact, push off, and swing. Then, 
the signal was segmented into separate gait cycles as described in Agostini et al.24 
The knee kinematic signal was low-pass filtered (finite impulse response filter; 100 
taps; cutoff frequency, 15Hz). In the analysis we considered only the walking along a 
linear path, discarding the strides related to direction changes. This is automatically 
managed by the system software. More specifically, a multivariate statistical filter 
(Hotelling t test, α=.05) discarded the outlier cycles (ie, strides with abnormal timing, 
such as those relative to deceleration, reversing, and acceleration). A video recording 
of the subject's walk was also captured, synchronous with gait signals. Subject 
preparation and signal acquisition overall required about 15 minutes. 
Fig 1.  (A) Footswitches placed under the foot sole. (B) Knee goniometer 
measuring the joint angle in the sagittal plane. (C) Walking path. 
 
Gait parameters 
For each foot, the system identifies the time events of the 4 gait phases (fig 2). It 
also calculates the double-limb support, defined as the percentage of the gait cycle in 
which both feet are in contact with the ground.27 Furthermore, it calculates the 
dynamic range of motion (ROM) of the knee joint, defined as the difference between 
the maximum and minimum flexion-extension angle observed during the gait cycle. 
Fig 2.  Schematization of gait phases (right foot). A dark circle under the foot 
sole indicates a closed footswitch. 
Summarizing, for each subject we considered the following 11 parameters: heel 
contact duration (left and right), flat-foot contact duration (left and right), as a 
percentage of the gait cycle; push-off duration (left and right), swing duration (left 
and right), double-limb support duration, all expressed as a percentage of the gait 
cycle, and dynamic ROM (left and right), in degrees. 
The gait parameter differences between patients and controls were estimated with 
Student t tests (2 samples; 2 tailed; level of significance, α=.05). 
Mahalanobis distance from controls and rule to select TT responders 
 
A preliminary analysis showed that no single parameter was sufficient to describe a 
patient's gait, but all of them were relevant. However, because our aim was to 
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compare the patient's performance before and after the TT, we found it important to 
obtain a single indicator scoring the patient's gait, rather than analyze many 
parameters separately. To this purpose, we calculated the Mahalanobis distance of 
each patient from the group of controls,28 using the 11 gait parameters previously 
defined. This multivariate distance describes how much a patient's performance 
deviates from the controls. We scored the performance of each patient before the TT, 
after the TT, and when the patient was operated on, after the shunt. 
Then we established if a patient's gait before the TT was altered with respect to the 
controls. Not suitable for the TT was defined as patients with normative gait. In fact, it 
is reasonable to avoid the TT (and surgery) in patients within the range of normality. 
The upper limit of this range was defined as the controls' mean Mahalanobis distance 
+ 3 SDs. Among patients suitable for the TT, we defined TT responders as those who 
decreased their Mahalanobis distance by at least 10%, after the TT, and 
nonresponders were defined as those who did not. To decrease the Mahalanobis 
distance (from controls) means getting closer to normative gait. 
We used custom software routinesb to calculate the Mahalanobis distances and 
select the TT responders. These routines are available on request. 
 
Gait velocity 
We calculated the gait velocity before and after the TT using video recordings. We 
timed each patient's passage through the 9-m walkway (see fig 1C). More specifically, 
we measured the time that the patient needed to walk from point P to point Q, then 
from point Q to point P, then from point P to point Q again, and so forth, timing each 
passage with the exclusion of direction changes. The average velocity was defined as 
the total distance walked in a straight line divided by the patient's total walking time 
along the straight line. Similarly to what is suggested in the literature,21 we defined 
velocity improvement as an increase in the velocity, after the TT, of at least 10%. 
 
Group matching 
A Student t test (2 samples; 2 tailed; level of significance, α=.05) was used to 
compare age between the INPH and control groups. A chi-square test for homogeneity 
of proportions was used to study sex differences between groups (α=.05). The INPH 
and control groups did not show significant differences for age (P=.35) or sex 
(P=.14). 
 
Sensitivity analysis 
In the presented methodology based on the Mahalanobis distance, we introduced 
the following 2 thresholds: the limit defining the range of normality (mean + 3 SDs) 
and the minimum Mahalanobis distance percentage change (10%), indicating a 
significant improvement after the TT. The values assigned to these thresholds is 
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reasonable but subjective. To test the robustness of the chosen values, we performed 
a sensitivity analysis,29 studying to what extent the results obtained depend on the 
chosen thresholds. 
 
Results 
The average distance that patients walked within 2.5 minutes was 80±40m, 
considering only the straight path. The gait parameters of the subjects included in the 
study are reported in table 1. Patients showed a decreased velocity, swing, and knee 
ROM and increased double support and flat-foot contact with respect to controls, both 
pre- and post-TT. 
 
Table 1   
 
Selection of TT responders using the Mahalanobis distance 
We selected 41 patients suitable for the TT and 19 not suitable for the TT. Among 
the 41 patients suitable for the TT, 22 responded to the TT and 19 did not. Hence, 
overall, 38 patients were not suitable for a shunt (19 not suitable for the TT, 19 
nonresponders). 
In figure 3, we reported, for each patient, the Mahalanobis distance value before 
the TT (indicated by an asterisk) and after the TT (indicated by a triangle). We also 
reported the Mahalanobis distance value after the shunt (indicated by a circle), when 
applicable. The range of normality spans between 0 and 26 arbitrary units. The 
horizontal line indicates the normality upper limit. The higher the Mahalanobis 
distance value, the worse the patient's gait impairment. Patients suitable for the TT 
are those indicated by asterisks above the horizontal line. Among them, the TT 
responders are highlighted by a rectangle. The further the triangle from the asterisk 
(below it), the higher the gait improvements are, because of the CSF tap. 
Fig 3.  Pre- and post-TT Mahalanobis distance for each patient. Postshunt 
Mahalanobis distance is also displayed, when applicable. Rectangles indicate tap test 
responders; arrow, operated patients classified as not suitable for a shunt. The 
horizontal line delimits the range of normality. Abbreviation: a.u., arbitrary units. 
Thirteen patients underwent shunt surgery. Nine of them were in the TT responder 
group (patient nos. 7, 12, 14, 18, 19, 28, 39, 44, 54). Four of them were in the group 
not suitable for shunt (indicated by an arrow in fig 3). More specifically, of these 4 
patients, 1 was in the group not suitable for the TT (patient no. 58), and 3 were in the 
group of nonresponders (patient nos. 3, 41, 57). 
In the group of TT responders, all of the patients improved after the shunt (9 of 9 
patients). Their Mahalanobis distance decreased on average from 147±144 (before 
the TT) to 84±95 arbitrary units (after the TT) and further decreased to 42±40 
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arbitrary units after the shunt. Hence, their improvements after the shunt were on 
average higher than those after the TT. More specifically, the Mahalanobis distance 
percentage decrement was 44%±21% after the TT and 59%±27% after the shunt. In 
the group of 4 patients not suitable for a shunt, 2 worsened their condition (1 was 
unable to walk 6mo after the shunt), 1 did not change his condition, and 1 improved 
after the shunt (see the Discussion for further details). Figure 4 outlines these results. 
 
Fig 4.  Schematization of the study results. 
 
Gait velocity 
Gait velocity improved in 53% of the TT responders and in 37% of patients not 
suitable for a shunt. More specifically, focusing on the latter, velocity improved in 29% 
of patients classified as not suitable for the TT and in 44% of nonresponders. 
In shunted patients, on average, the velocity increased after the TT from 0.5±0.3 
to 0.7±0.2m/s and further increased after the shunt (0.8±0.2m/s). Among the 9 
patients classified as TT responders, 3 did not improve their velocity after the TT. 
Among the 4 patients classified as not suitable for a shunt, 2 improved their velocity 
after the TT, but they did not improve after the shunt in velocity or Mahalanobis 
distance. 
 
Sensitivity analysis 
We varied the first threshold (defining the limit of normality) between (mean + 2.5 
SDs) and (mean + 3.5 SDs). When this first threshold was set to (mean + 2.5 SDs), 3 
more patients were classified as TT responders (error = 3/60 = 5%); however, 
considering (mean + 3.5 SDs), no change was obtained in the classification of TT 
responders (error = 0%). Varying the second threshold (minimum Mahalanobis 
distance percentage decrease) in the range of 5% to 15%, no change was obtained in 
the classification of TT responders (error = 0%). None of the aforementioned 
threshold variations altered the results presented for the 13 patients after the shunt 
(error = 0%). 
 
Discussion 
Clinicians have not reached a consensus on the usefulness and predictive value of 
the TT. The sensitivity and specificity reported are very variable from study to 
study.2, 5, 6, 8, 11 and 12 A major issue in establishing the prognostic value of the 
CSF tap is the method applied to document gait changes. The use of inadequate 
and/or subjective outcome measures may be a critical aspect.13 and 14 Furthermore, 
if gait improvements after the CSF tap are small, they can be missed by a clinical 
examination not supported by an instrumented test.13 
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We presented an objective method to score the patient's gait performance, before 
and after the TT, based on the measure of parameters extracted from an 
instrumented gait analysis lasting 2 to 3 minutes. We demonstrated that this 
approach is feasible in clinical practice. We are now routinely applying gait analysis for 
TT assessment in our center. 
We hypothesized that a functional improvement may be expected only in patients 
with clinically appreciable gait disturbances. Hence, it is useless to perform the TT in 
those whose gait is already in the range of normality. Therefore, a quantitative gait 
assessment before the TT allows for avoidance of unnecessary CSF taps. 
Of the patients, 37% responded to the TT. All the responders that were shunted (9 
out of 9) improved after surgery. Among the patients who were not candidates for a 
shunt, only 1 of the 4 patients improved after the shunt. However, deeper 
examination of this patient's clinical record revealed that he underwent an unusual 
CSF tap of <20mL. Such a limited tap was probably not sufficient to produce a 
noticeable clinical change. 
Literature reports that improvements after a TT seem to be positively correlated 
with improvements after shunt.12 Our results confirm this finding; however, more 
data are needed to explore this correlation. However, the possibility to quantify 
improvements after the TT, objectively and accurately, may be important to 
prognosticate the level of improvement after surgery. 
Patient's walking velocity is one of the most common measurement parameters 
used for evaluating TT responsiveness, and it is frequently assessed by the 10-m walk 
test. However, caution should be taken when considering velocity as the only 
parameter for describing TT responsiveness. Our results showed that velocity 
improved approximately in half of responders and in one third of patients who were 
not candidates for a shunt. This suggests that it is probably not sufficient to measure 
velocity for selecting shunt candidates. An explanation of this finding may be that 
velocity is biased by confounding factors, both in a positive or negative way. Among 
these factors are the habituation effect (ie, the fact that patients undergo the walking 
test for a second time during the day, perhaps feeling more confident and secure), 
fatigue effect because they are asked to fast for several hours, and pain because 
postlumbar puncture pain may negatively affect the gait function.21 
Measuring a gait parameter by an automatic analysis of many strides improves the 
parameter's estimation accuracy.22 Furthermore, choosing multiple parameters 
directly correlated to gait dysfunction provides a more reliable assessment than 
considering a single parameter. The parameters selected for this study well represent 
the INPH gait dysfunctions. An increase in the double-limb support duration is directly 
correlated to glue-footed or magnetic gait, whereas a reduced knee flexoextension is 
correlated with the attitude of walking with broad-based strides of reduced length. On 
the other hand, we decided to discard cadence from the analysis. Cadence is defined 
as the number of strides per minute. We found that this parameter may be misleading 
for the INPH population because pre- and postchanges may be difficult to interpret in 
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many practical situations. As an example, cadence may increase if velocity increases 
(functional improvement) or step length reduces (functional worsening). 
 
Study limitations 
We did not apply this technique to patients needing mobility aids (canes, walkers). 
This is only a partial limitation because some of the patients using walking aids before 
the TT were able to walk without them after the TT. In these cases, clinical 
improvement was evident without the need for an instrumented gait analysis. 
Among the 22 responders, only 9 were shunted. The remaining 13 patients were 
not operated on because of serious comorbidities (lung cancer, hepatocellular 
carcinoma, severe cardiomyopathy) or because they asked to procrastinate the 
intervention to a later date. 
 
Conclusions 
We proposed a new method to evaluate the effects of the CSF lumbar tap on gait. 
The method is promising both in terms of objectiveness and reliability. This approach 
is based on the use of many gait parameters specifically studied to describe INPH 
walking features, summarized in a single indicator (ie, Mahalanobis distance of a 
single patient from the control group). Furthermore, our findings suggest that gait 
velocity alone may not be sufficient to establish responsiveness to the TT. Therefore, 
simple tests (eg, 10-m walk test) may not be sufficiently reliable as an outcome 
evaluation of the CSF tap and may be the cause of the actual limited predictive value 
of the TT. 
 
Suppliers 
a. STEP32; Demitalia, Medical Technology. Available at: 
http://www.medicaltec.it/STEP32.html. 
b. MATLAB; MathWorks. 
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